Glycorex Transplantation AB Stock
Equities
GTAB B
SE0000524530
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 SEK | 0.00% | +30.49% | -19.25% |
Sales 2021 | 29.01M 2.67M | Sales 2022 | 37.39M 3.44M | Capitalization | 303M 27.82M |
---|---|---|---|---|---|
Net income 2021 | -12M -1.1M | Net income 2022 | -8M -735K | EV / Sales 2021 | 22.5 x |
Net cash position 2021 | 33.08M 3.04M | Net cash position 2022 | 23.52M 2.16M | EV / Sales 2022 | 7.47 x |
P/E ratio 2021 |
-56.1
x | P/E ratio 2022 |
-35.3
x | Employees | 23 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 95.58% |
1 week | +30.49% | ||
Current month | +25.88% | ||
1 month | +23.56% | ||
3 months | -20.74% | ||
6 months | -11.93% | ||
Current year | -19.25% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Laven
CEO | Chief Executive Officer | 51 | 21-12-31 |
Founder | 71 | 95-12-31 | |
Sales & Marketing | - | 22-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 71 | 95-12-31 | |
Nils Siegbahn
CHM | Chairman | 71 | 99-12-31 |
Clas Runnberg
BRD | Director/Board Member | 72 | 22-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.07 | 0.00% | 3,091 |
24-04-24 | 1.07 | +6.47% | 16,642 |
24-04-23 | 1.005 | +12.92% | 4,728 |
24-04-22 | 0.89 | -3.26% | 22,005 |
24-04-19 | 0.92 | +12.20% | 108,292 |
End-of-day quote NORDIC GROWTH MARKET, April 24, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-19.25% | 7.26M | |
+11.94% | 29.7B | |
-33.38% | 2.9B | |
-17.23% | 2.71B | |
+6.12% | 2.14B | |
-1.11% | 1.91B | |
-12.82% | 1.84B | |
-7.22% | 1.42B | |
-1.48% | 1.26B | |
+4.15% | 1.13B |
- Stock Market
- Equities
- GTAB B Stock